Array ( [0] => Array ( [id] => 5 [menu_id] => 2 [submenu_id] => 5 [title] => Milestones [label] => Milestones [content] =>

Milestones

  • 2019

    First product filing in China

  • 2018

    Enoxaparin injection approval received for US market

    First ophthalmic product approval received for US market

  • 2017

    Fosun Pharma acquires majority stake

  • 2016

    First USFDA approval for Penems plant in Hyderabad & Sterile Injectable plant at Pashamylaram, Hyderabad

    First USFDA approval for API plant in VSEZ & for API plant in Pharmacity, Visakhapatnam

  • 2014

    Dedicated facility for Penems commissioned at Pashamylaram, Hyderabad

    Manufacturing lines including Ophthalmic Line and Automated Bag Line added at Dundigal facility

    Gland enters Canada with Amiodarone PFS

  • 2013

    Enters Europe with Tirofiban

    Oncology formulations facility at Visakhapatnam receives USFDA acceptance

  • 2012

    Dundigal formulations facility receives UK MHRA and EMEA approvals

  • 2011

    Forays into Australia with Azithromycin Injection.

    Rocuronium, the first product approval in New Zealand

  • 2010

    Introduces Heparin, its flagship product, in the US market

  • 2007

    Enters the US market with Ketorolac PFS

  • 2003

    Dundigal formulations facility receives USFDA acceptance

  • 2002

    Supplies Enoxaparin in Brazil and other semi-regulated markets

  • 2001

    Launches Enoxaparin injectionin India

  • 2000

    Signs its first Contract Manufacturing agreement for regulated markets

    R&D facility set up at Dundigal, Hyderabad

  • 1998

    Flagship manufacturing facility at Dundigal becomes operational

  • 1996

    Becomes the first company to set up a PFS facility in India, in collaboration with Vetter Pharma, Germany

  • 1994

    Becomes a public limited company from a private limited company

  • 1978

    PVN Raju founds Gland Pharma to manufacture and market Heparin injection for the domestic market and provides contract manufacturing services for other pharmaceutical companies

[description] => [type] => sub-page [is_deleted] => 0 [deleted_at] => 0000-00-00 00:00:00 [created_at] => 2020-06-08 06:59:50 [updated_at] => 2020-06-24 04:26:40 ) )

Milestones

  • 2019

    First product filing in China

  • 2018

    Enoxaparin injection approval received for US market

    First ophthalmic product approval received for US market

  • 2017

    Fosun Pharma acquires majority stake

  • 2016

    First USFDA approval for Penems plant in Hyderabad & Sterile Injectable plant at Pashamylaram, Hyderabad

    First USFDA approval for API plant in VSEZ & for API plant in Pharmacity, Visakhapatnam

  • 2014

    Dedicated facility for Penems commissioned at Pashamylaram, Hyderabad

    Manufacturing lines including Ophthalmic Line and Automated Bag Line added at Dundigal facility

    Gland enters Canada with Amiodarone PFS

  • 2013

    Enters Europe with Tirofiban

    Oncology formulations facility at Visakhapatnam receives USFDA acceptance

  • 2012

    Dundigal formulations facility receives UK MHRA and EMEA approvals

  • 2011

    Forays into Australia with Azithromycin Injection.

    Rocuronium, the first product approval in New Zealand

  • 2010

    Introduces Heparin, its flagship product, in the US market

  • 2007

    Enters the US market with Ketorolac PFS

  • 2003

    Dundigal formulations facility receives USFDA acceptance

  • 2002

    Supplies Enoxaparin in Brazil and other semi-regulated markets

  • 2001

    Launches Enoxaparin injectionin India

  • 2000

    Signs its first Contract Manufacturing agreement for regulated markets

    R&D facility set up at Dundigal, Hyderabad

  • 1998

    Flagship manufacturing facility at Dundigal becomes operational

  • 1996

    Becomes the first company to set up a PFS facility in India, in collaboration with Vetter Pharma, Germany

  • 1994

    Becomes a public limited company from a private limited company

  • 1978

    PVN Raju founds Gland Pharma to manufacture and market Heparin injection for the domestic market and provides contract manufacturing services for other pharmaceutical companies

Enquire now